January 20th 2025, 4:00pm
By Alex Biese
Ten days of subcutaneous Dacogen resulted in responses among a third of patients with myelofibrosis.
January 20th 2025, 2:00pm
By Ryan Scott
Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means for those with solid tumors.
January 19th 2025, 7:00pm
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.
January 18th 2025, 7:00pm
By Spencer Feldman
PH284 increased feelings of hunger and was safe in patients with cancer cachexia, which results in significant weight loss.
January 18th 2025, 3:00pm
CURE spoke with an expert about how psychedelics such as psilocybin may impact patients’ mental health.
January 17th 2025, 10:00pm
An expert explains the new phase of Princess Kate’s cancer journey as she enters remission.
January 17th 2025, 6:54pm
Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.
January 17th 2025, 6:00pm
By Joe Bullock
As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their legacy of advocacy.
January 17th 2025, 4:00pm
From the death of a TikTok influencer to an update from a “Boy Meets World” star, here is this week’s news.
January 17th 2025, 2:00pm
Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.
January 16th 2025, 11:50pm
The FDA has approved Lumakras with Vectibix for adults with KRAS G12C-mutated metastatic colorectal cancer who received chemotherapy.
January 16th 2025, 11:17pm
The Food and Drug Administration has granted traditional approval to Calquence with bendamustine and Rituxan for some patients with MCL.
January 16th 2025, 10:00pm
Dr. Christopher R. Flowers delved into the meaning of MRD, discussing different ways that it may be tested for in patients with various types of cancer.
January 16th 2025, 8:00pm
A diet high in omega-3 fatty acids and low in omega-6 fatty acids, taken with fish oil, reduced the Ki-67 index in men with prostate cancer on active surveillance.
January 16th 2025, 6:00pm
By Mike Verano
Fifteen years after my own cancer journey, I find myself balancing hope and grief as I support a colleague newly diagnosed with cancer.
A Close Companion Throughout my Cancer Journey
Could Cancer Vaccines Become a Reality Within the Next Decade?
Breaking Down the Treatment of GIST for Patients
How My Daughter’s Cancer Team Helped Me Stay Her Mom